Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07A BACTERIAL VACCINES
J07AL Pneumococcal vaccines
J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
D12207 Pneumococcal 20-valent conjugate vaccine <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Vaccines
Pneumococcal
Pneumococcal Conjugate Vaccine 20-valent (PCV20), Polysaccharide CRM197 Conjugate, Adjuvant, PF
D12207 Pneumococcal 20-valent conjugate vaccine
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
631 Vaccines
6311 Bacterial vaccines
D12207 Pneumococcal 20-valent conjugate vaccine
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12207
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12207
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12207
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12207